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Abstract 2-Substituted hydrazinecarbothioamides and N,2-disubstituted hydrazinecarbothioa-
mides react in high yield with dimethyl acetylenedicarboxylate (DMAD) to give 4-oxo-Z-(thiazoli-
din-5-ylidene) acetate derivatives. Several mechanistic options involving interaction are presented.
The structures of thiazolidin-4-ones have been unambiguously confirmed by single crystal X-ray
crystallography.
ª 2014 TheAuthors. Production and hosting by Elsevier B.V. on behalf of King SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
The reaction of hydrazinecarbothioamides with tetracyanoeth-
ylene, 3-(dicyanomethylene)-2-indolone and benzo- as well as
naphthoquinones is a convenient method for the synthesis of
various heterocyclic compounds, such as pyrazolo[1,2-c]-
1,3,4-thiadiazoles (Hassan et al., 2003), spiro(indolone-3,20-
[1,3,3]thiadiazole)-2-ones (Hassan et al., 2011), indazoles
(Hassan et al., 2007) and thiadiazines (Hassan et al., 2007),
respectively.
Acetylenedicarboxylates can be used as Michael acceptor
and reacted with various nucleophiles containing sulfur and
nitrogen atoms such as thiourea derivatives leading to forma-
tion of substituted thiazoles, 1,3-thiazolidin-4-ones and thia-
zine-4-ones (Gao, 2010; Castagnolo et al., 2009; Imrich
et al., 2010; Böhm et al., 2009; Ahmadi et al., 2009).
Thiazoles are synthetic intermediates and common sub-
structures in numerous biologically active compounds (Sun
et al., 2008; Miwatashi et al., 2005; Pereira et al., 2006;
Wang et al., 2005; Lentzen et al., 2003; Yavari et al., 2007).
Owing to the various physiological activities of thiazolidinon-
es, many thiazolidinone derivatives have been prepared and
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ith 2. These results are compared with those obtained in
cheme 1 (Aly et al., 2008). As shown in Scheme 2, the synthe-
is of thiazolidin-4-ones 5 and 6 was simply affected by the
ucleophilic active centers in hydrazinecarbothioamides 4a–e
nd an electrophilic acetylenic ester (DMAD, 2). The reaction
roceeds smoothly without using any catalyst by treatment of
a–e with one molar equivalent of dimethyl acetylenedicarbox-
late (DMAD, 2) in ethanol at reflux resulting in the formation
f single products 5a,b and 6a–c in 78–89% yield (Scheme 2).
Elemental analyses and mass spectra clearly revealed that
he products were formed by the addition of equimolar of
DMAD, 2) and 4a–e with elimination of one molecule of
ethanol. There are possibilities for the formation of various
somers which would behave spectroscopically very similar.
ydrazinecarbothioamides, N1, N2, N4 and sulfur atom are
he nucleophilic sites in compounds 4a–e.
Thus, several options for the interaction between 4a–e and


























































ig. 1 Expected intermediates (1:1) (A-E) through interactions
etween 4a–e and 2.
290 A.A. Hassan et al.several new methods for the preparation of substituted thiaz-
olidin-4-ones have been reported (Yavari et al., 2007;
Sunduru et al., 2009). Thiazolidin-4-one compounds, display
anti-microbial (Aridoss et al., 2009), anti-mycobacterial (de
Aquino et al., 2008), anti-HIV (Rawal, 2007), anti-inflamma-
tory (Ottaná et al., 2005), and anti-cancer activities (Vicini
et al., 2003).
1,3-Thiazolidin-4-ones were observed as the only product
during the reaction of thiosemicarbazide and thiosemicarba-
zone derivatives with acetylenedicarboxylates (Yavari et al.,
2007; Aly et al., 2010, 2014; Hassan et al., 2012, 2014a,b).
One-pot three component reactions containing diethyl acety-
lenedicarboxylate, thiosemicarbazones and arylidenemalono-
nitrile afforded thiazolidine derivatives (Aly et al., 2014).
Also, the reaction of 4-phenylthiosemicarbazide, dimethyl
acetylenedicarboxylate (DMAD) in the presence of aldehydes
and ketones gave thiazolidine-4-ones (Yavari et al., 2007).
Treatment of diacylthiosemicarbazides (Aly et al., 2010), 1,4-
thiosemicarbazides (Hassan et al., 2014a) and thiocarbohyd-
razides (Hassan et al., 2012, 2014b) with DMAD afforded thi-
azolidine-4-one derivatives.
Methyl [3-aryl-4-oxo-1-(phenylthiocarbamoyl)-4,5-dihy-
dro-pyrazol-5-ylidene]ethanoates were formed from the reaction
of arenealdehyde 4-phenylthiosemicarbazones with dimethyl
acetylenedicarboxylate (DMAD, 2) (Hassan et al., 2008),
whereas 1,2,4-triazepine-3-thiones 3a–g were formed via con-
ventional and microwave irradiation of 4-substituted thiose-
micarbazides 1a–c and 2,4-disubstituted thiosemicarbazides
1d–g with (DMAD, 2) (Scheme 1) (Aly et al., 2008).
2. Result and discussion
We report here the results of our investigations on the reaction



















observed are formed from one of the five labile (1:1) interme-
diates (A–E) (Fig. 1).
To elucidate the tautomeric states and structure of the
products as well as to characterize the products, we use IR,
1H NMR and 13C NMR as well as mass spectrometry.
Rigorous structure proof comes from the single crystal X-ray
structural analyses of 5b (Fig. 2) and 6b (Fig. 3).
To illustrate the structure elucidation of compound 5a,b we
choose 5b, IR spectrum showed two carbonyl absorption
bands at 1745 and 1685 (C‚O) and a band at 1615 cm1 that
assigned to C‚N vibration. Broad bands at 3310, 3160 cm1














1. 3:a, R = C6H5, R1 = H; b, R = C6H5-CH2, R1 = H;
c, R = CH2=CH-CH2, R1 = H; d, R = R1 = C6H5;
e, R = C6H5-CH2, R1 = C6H5; f, R = C6H5-CH2, R1 = 4-CH3-C6H4;


















4: a, R = C6H5, R' = H; b, R = , R' = H;
c, R = R' = C6H5; d, R = C6H5, R' = C2H5;
















6: a, R = R' = C6H5; b, R = C6H5, R' = C2H5;
c, R = C6H5, R' = CH2=CH-CH2













R' = HR' = Ph; Et;
82-89%78-84%
Scheme 2 Reactions of hydrazinecarbothioamides 4a–e with dimethyl acetylenedicarboxylate 2.
The 1H NMR spectrum of 5b showed one methoxy group
at dH = 3.86, methyl group at dH = 2.24 ppm, one phenyl
group in the range of dH = 6.85–7.24, one vinylic proton at
dH = 6.85 and NH at dH = 8.27. In 5b, the
13C NMR spectra
show five downfield lines at 168.12, 166.64, 145.94, 140.22 and
115.73 ppm, attributed to (C‚O, ester), (C-4), (C‚N), (C-5)
and vinyl-CH, respectively. Full 1H NMR and 13C NMR data
are given in the experimental part.
Moreover, the structure of Z-methyl-2-[(Z)-4-oxo-2-(2-
tosylhydrazono)-thiazolidin-5-ylidene]acetate 5b has been
unambiguously confirmed by a single crystal X-ray structure
analysis (Fig. 2 and Tables S1–7 in the supplementary data)
which confirms a cisoid geometry with respect to C‚C and
C‚N double bonds. Also, the vinyl-CH is in cis form with
the cyclic C‚O. The thiazolidine moiety is planar.
On the other hand, solutions of 4c–e (1 mmol) in absolute
ethanol (15 mL) were added into a solution of 2 (1 mmol) in
absolute ethanol (10 mL); the mixture was refluxed for
8–10 h, which later turned into orange precipitates from 6a–c.
The IR spectra of the isolated compounds from the reaction
of 2 with 4c–e showed two carbonyl absorption bands about
1690–1725 cm1, and a band between 1635 and 1655 cm1 that
was assigned to a C‚N vibration. A broad band at 3295–
3320 cm1 is due to the NH group. The 1H NMR spectrum
of 6c as an example clearly indicated the presence of an allyl
group which appeared as three multiplets centered at 4.15,
5.12 and 5.92 ppm due to (allyl-CH2N), (allyl-CH2‚) and
(allyl,ACH‚), respectively. The presence of the allyl group
was also proved by the 13C-DEPT-NMR spectrum, exhibiting
positive signals at 133.72 (allyl-CH‚) and negative signal at
45.24 and 117.15 due to (allyl-CH2N) and (allyl-CH2‚),
respectively.
Unambiguous support for these came from the X-ray struc-
ture analysis of (Z)-methyl-2-[(Z)-2-(ethylimino)-4-oxo-3-(phe-
nylamino) thiazolidin-5-ylidene)]acetate 6b (Fig. 3 and Tables
S8–14, in the supplementary data). A cisoid geometry with
respect to C‚C and C‚N double bonds and the thiazolidine
moiety is planar.
There are possibilities for the formation of various isomers,
which would behave very similarly spectroscopically (Schemes
3 and 4). Isomeric products 7–9 (Scheme 3) may be formed as
following:
If 1NH attacked C/C triple bond of 2, the intermediate A
(Fig. 1) could be formed, leading to the product 7 after elimi-
nation of a molecule of MeOH (Scheme 3).
The products 8 and 9 (Scheme 3) could be isolated if the reac-
tion involved the addition of thiosemicarbazidesA2NHorA4NH
on the C/C triple bond of 2 via intermediates B or E (Fig. 1).
Fig. 2 Molecular structure of 5b in the crystal (displacement parameters are drawn at 50 % probability level). The crystallographic
numbering does not reflect the systematic IUPAC numbering.
Fig. 3 Molecular structure of 6b in the crystal (displacement parameters are drawn at 50% probability level). The crystallographic
numbering does not reflect the systematic IUPAC numbering.
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A rationale for the formation of products 5a,b and 6a–c is
depicted in Scheme 4. Nucleophilic attack of SH of 4a–e on the
triple bond of 2 through the intermediate (C), followed by
intramolecular nucleophilic attack of the NH2 of 4a,b at
a-ester carbonyl group, the products 5a,b would be isolated,
where via the intermediate (D) and nucleophilic attack of SH
on the triple bond of 2 with elimination of one molecule of
MeOH during the attack of N-hydrazinecarbothioamide at
the carbonyl ester, the thiazolidin-4-ones 6a–c would be formed.
3. Conclusion
Reaction of 2-substituted hydrazinecarbothioamides 4a,b
and N,2-disubstituted hydrazinecarbothioamides 4c–e with
DMAD (2) can involve possible competition between nucleo-
philic addition of several sites (N1, N2, N4 and SH of hydra-
zinecarbothioamides group) to the triple bond of activated




All melting points were determined using open capillaries on a
Gallenkamp melting point apparatus. The IR spectra were
recorded with a Shimadzu 408 instrument using potassium
bromide. The 400 MHz 1H NMR and 100 MHz 13C NMR
spectra were observed on a Bruker AM 400 spectrometer with
tetramethylsilane as the internal standard, br = broad,
s = singlet, d = doublet, t = triplet, q = quartet, m = multi-
plet. The 13C NMR signals were assigned on the basis of
DEPT 135/90 spectra. The mass spectra (70 eV, electron
impact mode) were recorded on a Finnigan MAT instrument.
Elemental analyses were carried out at the Microanalytical
Center, Cairo University, Egypt. Preparative layer chromatog-
raphy (plc) used air dried 1.0 mm thick layers of slurry applied
silica gel (Merck Pf254) on 48 cm wide and 20 cm high glass
plates using the solvents listed. Zones were detected by quench-
ing of indicator fluorescence upon exposure to 254 nm light
and eluted with acetone.
4.2. Starting materials
2-Substituted hydrazinecarbothioamides 4a,b and N,2-disub-
stituted hydrazinecarbo-thioamides 4c–e were prepared
according to the literature: 4a (Lee and Lee, 2000), 4b
(Zaharia et al., 2010), 4c (El-Metwally et al., 2005), 4d
(El-Metwally et al., 2005) and 4e (Jaźwiński and Staszewska-
Krajewska, 2004). Dimethyl acetylenedicarboxylate (DMAD,
2) was bought from Fluka.
4.3. Products
4.3.1. Reaction of substituted hydrazinecarbothioamides 4a–e
with dimethyl acetylenedicarboxylate (2)
A mixture of substituted hydrazinecarbothioamides 4a–e
(1 mmol) and dimethyl acetylenedicarboxylate (2) (0.142 g,
1 mmol), in absolute ethanol (30 mL) was refluxed for 8–
10 h, cooled to room temperature. Yellow crystals from 5a,b
were precipitated, filtered and washed with a small amount
of cold ethanol and recrystallized from listed solvents. The
reaction mixture between 4c–e and 2 was pre-concentrated,
applied to chromatographic plates and developed using tolu-
ene/ethyl acetate (Qr = 10:1) to give only one zone containing
compounds 6a–c. The products so obtained were
recrystallized.
4.3.1.1. (Z)-Methyl-2-[(Z)-4-oxo-2-(2-phenylhydrazno)-
thiazolidin-5-ylidene]acetate (5a, C12H11N3O3S). Yellow
crystals (0.246 g, 89%), mp. 222 C (acetonitrile); IR (KBr)
m = 3288, 3252 (NH), 1692, 1668 (CO), 1640 (C‚N), 1605
(ArAC‚C) cm1; 1H NMR (400 MHz, CDCl3): d = 3.85 (s,
3H, OCH3), 6.85 (m, 2H, ArAH and vinyl-CH), 7.24 (m,
4H, ArAH), 8.27 (br, s, 1H, NH), 11.27 (br, s, 1H, thiazole-
NH); 13C NMR (100 MHz, CDCl3): d = 52.71 (OCH3),
116.12 (vinyl-CH), 122.81, 127.19, 129.67 (ArACH), 140.12
(thiazole-C5), 142.88 (ArAC), 146.12 (thiazole-C2), 166.73
(thiazole-C4), 168.19 (CO-ester); MS (70 eV): m/z = 277
(M+, 100), 246 (12), 218 (19), 145 (22), 105 (39), 92 (54), 77
(62), 65 (42), 59 (21). Anal. Calcd: C, 51.98; H, 4.00; N,
15.15; S, 11.56. Found: C, 52.11; H, 3.88; N, 15.06; S, 11.74.
4.3.1.2. (Z)-Methyl 2-[(Z)-4-oxo-2-(2-tosylhydrazono)thiaz-
olidin-5-ylidene] acetate (5b, C13H13N3O5S2). Yellow crystals
(0.290 g, 82 %), mp. 234 C (acetonitrile); IR (KBr) m = 3310,
3160 (NH), 1745, 1685 (CO), 1615 (C‚N), 1590
(ArAC‚C) cm1; 1H NMR (400 MHz, CDCl3): d = 2.24 (s,
3H, CH3), 3.86 (s, 3H, OCH3), 6.80 (s, 1H, vinyl-CH), 6.90–
7.00 (m, 2H, ArAH), 7.28 (m, 2H, ArAH), 8.45 (br, s, 1H,
NH), 11.16 (br, s, 1H, thiazole-NH); 13C NMR (100 MHz,
CDCl3): d = 22.16 (CH3), 52.75 (OCH3), 115.73










































































Scheme 4 The mechanism for the formation of products 5a, b
and 6a–c.
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(thiazole-C5), 143.42 (ArAC), 145.94 (thiazole-C2), 166.64
(thiazole-C4), 168.12 (CO-ester); MS (70 eV): m/z = 355
(M+, 21), 324 (12), 200 (100), 155 (11), 117 (23), 91 (37). Anal.
Calcd: C, 43.93; H, 3.69; N, 11.82; S, 18.04. Found: C, 44.14;
H, 3.78; N, 11.67; S, 17.91.
4.3.1.3. (Z)-Methyl-2-[(Z)-4-oxo-3-(phenyl-amino)-2-(phe-
nylimino)-thiazolidin-5-ylidene]acetate (6a, C18H15N3O3S)
Pal et al., 2014. Yellow crystals (0.286 g, 81%).
4.3.1.4. (Z)-Methyl 2-[(Z)-2-(ethylimino)-4-oxo-3-(phenyla-
mino)thiazolidin-5-ylidene]acetate (6b, C14H15N3O3S). Yel-
low crystals (0.256 g, 84%), mp. 151 C (acetone); IR (KBr):
m = 3310 (NH), 1695, 1725 (CO), 1655 (C‚N), 1615
(ArAC‚C) cm1; 1H NMR (400 MHz, CDCl3): d = 1.15 (t,
3H, J = 7.6 Hz, CH3), 3.40 (q, 2H, J = 7.6 Hz, CH2) 3.85
(s, 3H, OCH3), 6.50 (s, 1H, vinyl-CH), 6.73 (m, 2H, ArAH),
6.92 (m, 2H, ArAH), 7.20 (m, 2H, ArAH and NH); 13C
NMR (100 MHz, CDCl3): d = 15.67 (CH3), 47.21 (CH2),
52.65 (OCH3), 115.05 (vinyl-CH), 116.82, 122.82, 129.23
(ArACH), 138.78 (thiazole-C5), 145.16 (ArAC), 145.77 (thia-
zole-C2), 162.24 (thiazole-C4), 166.28 (CO-ester); MS
(70 eV): m/z = 305 (M+, 100), 290 (11), 274 (18), 247 (11),
134 (38), 106 (21), 92 (16). Anal. Calcd: C, 55.07; H, 4.95; N,
13.76; S, 10.50. Found: C, 54.97; H, 5.02; N, 13.85; S, 10.39.
4.3.1.5. (Z)-Methyl 2-[(Z)-2-(allyimino)-4-oxo-3-(phenyla-
mino)thiazolidin-5-ylidene]acetate (6c, C15H15N3O3S). Yellow
crystals (0.247 g, 78%), mp. 129 C (acetone). IR (KBr):
m = 3320 (NH), 1710, 1695 (CO), 1650 (C‚N), 1605
(ArAC‚C) cm1. 1H NMR (400 MHz, CDCl3) d = 3.88 (s,
3H, OCH3), 4.15 (m, 2H, allyl-CH2), 5.12 (m, 2H, allyl-
CH2‚), 5.92 (m, 1H, allyl-CH‚), 6.60 (s, 1H, vinyl-CH),
6.85 (m, 1H, ArAH), 7.0 (m, 2H, ArAH), 7.3 (m, 2H, ArAH
and NH); 13C NMR (100 MHz, CDCl3): d = 45.24 (allyl-
CH2N), 52.61(OCH3), 115.36 (vinyl-CH), 117.15 (allyl-
CH2‚), 122.85, 129.26, 129.26 (ArACH), 133.72 (allyl-
CH‚), 140.51 (thiazole-C5), 141.46 (ArAC), 145.61 (thia-
zole-C2), 162.92 (thiazole-C4), 166.56 (CO-ester); MS
(70 eV): m/z = 317 (M+, 100), 286 (13), 258 (9), 225 (14), 92
(33). Anal. Calcd: C, 56.77; H, 4.76; N, 13.24; S, 10.10. Found:
C, 56.89, H, 4.68; N, 13.12; S, 10.24.
4.4. Single crystal X-ray structure determination of 5b and 6b
Suitable crystals were obtained by recrystallization from aceto-
nitrile. The single crystal X-ray diffraction study was carried
out on a Bruker-Nonius ApexII diffractometer at 123(2) K
(5b) or a Bruker Apex Duo at 120(2) K (6b) using MoKa radi-
ation (k = 0.71073 Å). Direct Methods (SHELXS-97)
Sheldrick, 2008 were used for structure solution and refine-
ment was carried out using SHELX-97 (Sheldrick, 2008),
(full-matrix least-squares on F2). Hydrogen atoms were local-
ized by difference electron density determination and refined
using a riding model (H(N) free). An extinction correction
was applied for 5b and a semi-empirical absorption correction
was applied for 6b.
Compound 5b: C13H13N3O5S2, M = 355.38 g mol
1, yellow
crystals, crystal size 0.50 · 0.45 · 0.40 mm, orthorhombic,
space group Pbca (No. 61), a = 13.8883(3) Å, b=
12.8134(4) Å, c = 16.8953(5) Å, V= 3006.63(14) Å3, Z= 8,
Dcalcd = 1.570 Mg m
3, l = 0.384 mm1, T = 123(2) K,
14529 reflection, 3424 unique [Rint = 0.019], 2hmax = 55,
217 parameters, 2 restraints, R1 [for 3198 I > 2r(I)] = 0.028,
wR2 (all data) = 0.074, S = 1.12, largest diff. peak and
hole = 0.385/0.347 e A3.
Compound 6b: C14H15N3O3S, Mr = 305.35 g mol
1, yellow
crystal, crystal size 0.50 · 0.30 · 0.20 mm, monoclinic, space
group P21/n (No. 14), a = 7.3170(2) Å, b = 10.8893(3) Å,
c = 17.6717(5) Å, b = 96.992(1) Å, V= 1397.56(7) A3,
Z= 4, Dcalcd = 1.451 Mg m
3, l = 0.246 mm1, T =
120(2) K, 11,545 reflection, 3144 unique [Rint = 0.012],
2hmax = 55, 194 parameters, 1 restraint, R1 [for 2967 I> 2r
(I)] = 0.028 WR2 (all data) = 0.072, S= 1.04, largest diff.
peak and hole = 0.370/0.232 e A3.
Crystallographic data (excluding structure factors) for the
structures reported in this work have been deposited with the
Cambridge Crystallographic Data Centre as supplementary
publication number CCDC 918764 (5b) and CCDC 918765
(6b). Copies of the data can be obtained free of charge on
application to The Director, CCDC, 12 Union Road,
Cambridge DB2 1EZ, UK (Fax: int.code + (1223)336-033;
e-mail: deposit@ccdc.cam.ac.uk).
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.arabjc.
2014.10.035.
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Arkivoc i, 118–128.
Hassan, A.A., Ibrahim, Y.R., Shawky, A.M., 2007. J. Sulfur Chem.
28, 211–222.
Hassan, A.A., Shehatta, H.S., Döpp, D., 2008. J. Chem. Res., 725–
730.
Hassan, A.A., Abdel-Latif, F.F., Nour El-Din, A.M., Abdel-Aziz, M.,
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Jaźwiński, J., Staszewska-Krajewska, O., 2004. J. Mol. Struct. 687, 23–
33.
Lee, B.W., Lee, S.D., 2000. Tetrahedron Lett. 41, 3883–3886.
Lentzen, G., Klinck, R., Matassova, N., Aboul-ela, F., Murchie,
A.I.H., 2003. Chem. Biol. 10, 769–778.
Miwatashi, S., Arikawa, Y., Kotani, E., Miyamoto, M., Naruo, K.-I.,
Kimura, H., Tanaka, T., Asahi, S., Ohkawa, S., 2005. J. Med.
Chem. 48, 5966–5979.
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